COPYRIGHT TRANSFER FORM

 

AUTHOR CONTRIBUTION FORM

ICMJE FORM

Psychiatry and Clinical Psychopharmacology ) is the official journal of the Turkish Association for
Psychopharmacology. It is published quarterly, and four editions annually constitute a volume.
Psychiatry and Clinical Psychopharmacology is a peer reviewed scientific journal that publishes
articles on psychiatry, neurology, and behavioural sciences. Both clinical and basic science
contributions are welcomed. Submissions that address topics in the interface of neurology and
psychiatry are encouraged. The content covers original research articles, reviews, letters to the
editor, and case reports.

The audience of the journal includes neurologists, psychiatrists, and other scientists and clinicians
working in related fields.

Psychiatry and Clinical Psychopharmacology is an international journal indexed/abstracted in the
Science Citation Index-Expanded (SCI-E), PubMed Central, Journal Citation Reports/Science
Edition, EMBASE, ProQuest, SCOPUS, EBSCO, PSYCHinfo, CINAHL, Gale/Cengage Learning,
British Library Direct, Turkish Psychiatry Index, and TUBITAK ULAKBIM TR Index databases.
Printed versions include articles in the language they were written: They are available free of charge
to the members of the Turkish Neuropsychiatic Society. Online versions include all articles in both
Turkish and English, and they are open to free access without a date quota.

The editorial and publication processes of the journal are shaped in accordance with the guidelines
of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical
Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics
(COPE), European Association of Science Editors (EASE), and National Information Standards
Organization (NISO). The journal is in conformity with the Principles of Transparency and Best
Practice in Scholarly Publishing (doaj.org/bestpractice).

Submissions are reviewed for their originality and scientific quality. Manuscripts submitted should not
have been previously published in an electronic or printed medium, nor should be under evaluation
process with another journal. Authors may wish to inform the journal of the reviewer reports of their
previously evaluated manuscripts. The submission of previous reviewer reports will expedite the
evaluation process. Manuscripts that have been presented at scientific meetings should be
accompanied by information about the organization, including the name, date, and location of the
meeting.

The decision about the publication of manuscripts is based on independent, unbiased, double-blind
peer-review. The editorial board completes an initial evaluation of submissions for their originality,
methodology, the importance of the subject covered, and its relevance to neuropsychiatry. This is
followed by an unbiased double-blind peer-review by two or more independent experts in the field.
The editorial board will invite an external and independent editor to manage the evaluation processes
of manuscripts submitted by editors or by the editorial board members of the journal. For all
submissions, the Editor in Chief is the final authority in the decision-making process.

Approval of research protocols by the Ethics Committee in accordance with international agreements
(World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving
Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical,
and drug studies and for some case reports. If required, ethics committee reports or an equivalent
official document must be provided by the authors. For experimental human research studies, a
statement should be included in the manuscript depicting written informed consent of patients and
volunteers has been obtained following a detailed explanation of the procedures that they may
undergo. For animal studies, the measures taken to prevent pain and suffering of the animals should
be stated clearly. Information on patient consent, the name of the ethics committee, and the ethics
committee approval number should also be stated in the Materials and Methods section of the
manuscript. It is the authors’ responsibility to carefully protect the patients’ anonymity. For
photographs that may reveal the identity of the patients, signed releases of the patient or of their
legal representatives should be enclosed.

All submissions are screened by a similarity detection software (iThenticate by CrossCheck).
In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and
data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE
guidelines.

Each individual listed as an author should fulfill the authorship criteria recommended by the
International Committee of Medical Journal Editors (ICMJE – www.icmje.org). The ICMJE
recommends that authorship be based on the following 4 criteria:

1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately investigated and resolved.
In addition to being accountable for the parts of the work he/she has done, an author should be able
to identify which co-authors are responsible for specific parts of the work. In addition, authors should
have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four
criteria should be identified as authors. Those who do not meet all four criteria should be
acknowledged in the title page of the manuscript.

At initial submission Psychiatry and Clinical Psychopharmacology expects from corresponding
authors a signed and scanned version of the authorship contribution form (available for download
through www.noropsikiyatriarsivi.com) in order to act appropriately on authorship rights and to
prevent ghost or honorary authorship. If the editorial board suspects a case of “gift authorship,” the
submission will be rejected without further review. As part of the submission of the manuscript, the
corresponding author should also send a short statement declaring that he/she accepts to undertake
all the responsibility for authorship during the submission and review stages of the manuscript.
Psychiatry and Clinical Psychopharmacology requires and encourages the authors and the
individuals involved in the evaluation process of submitted manuscripts to disclose any existing or
potential conflicts of interests, including financial, consultant, and institutional, that might lead to
potential bias or a conflict of interest. Any financial grants or other support received for a submitted
study from individuals or institutions should be disclosed to the Editorial Board. To disclose potential
conflicts of interest, the ICMJE Potential Conflict of Interest Disclosure Form should be filled in and
submitted by all contributing authors. Cases of a potential conflict of interest of the editors, authors,

or reviewers are resolved by the journal’s Editorial Board within the scope of COPE and ICMJE
guidelines.

The Editorial Board of the journal handles all appeal and complaint cases within the scope of COPE
guidelines. In such cases, authors should get in direct contact with the editorial office regarding their
appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that
cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process
for all appeals and complaints.

When submitting a manuscript to Archives of Neuropsychiatry, authors accept to assign the copyright
of their manuscript to the Turkish Neuropsychiatric Society. If rejected for publication, the copyright of
the manuscript will be assigned back to the authors. Psychiatry and Clinical Psychopharmacology
requires each submission to be accompanied by a Copyright Transfer Form (available for download
at www.pcpjournal.net. When using previously published content, including figures, tables,
or any other material in both print and electronic formats, authors must obtain permission from the
copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).
Any opinions and views expressed in the articles published by the journal are the views and opinions
of the author(s), and not views of or endorsed by the Turkish Neuropsychiatric Society, editors,
editorial board, and/or publisher; the editors, editorial board, and publisher disclaim any responsibility
or liability for such materials.

MANUSCRIPT PREPARATION

The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals (updated in December
2016 – http://www.icmje.org/icmje-recommendations.pdf). Authors are required to prepare
manuscripts in accordance with the CONSORT guidelines for randomized research studies,
STROBE guidelines for observational original research studies, STARD guidelines for studies on
diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE
guidelines for experimental animal studies, and TREND guidelines for non-randomized public
behavior.

Manuscripts can only be submitted through the journal’s online manuscript submission and
evaluation system, available at www.noropsikiyatriarsivi.com. Manuscripts submitted via any other
medium will not be evaluated.

Manuscripts submitted to the journal will first go through a technical evaluation process where the
editorial office staff will ensure that the manuscript has been prepared and submitted in accordance
with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be
returned to the submitting author with technical correction requests.

Authors are required to submit the following during the initial submission:
• Copyright Transfer Form,
• Author Contributions Form, and
• ICMJE Potential Conflict of Interest Disclosure Form (should be completed by all contributing
authors)
These forms are available for download at www.noropsikiyatriarsivi.com.
Preparation of the Manuscript
Title page: A separate title page should be submitted with all submissions and this page should
include:
• The full title of the manuscript as well as a short title (running head) of no more than 50 characters,
• Name(s), affiliations, and highest academic degree(s) of the author(s),
• Grant information and detailed information on the other sources of support,
• Name, address, telephone (including the mobile phone number) and fax numbers, and email
address of the corresponding author,
• Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do
not fulfill the authorship criteria.
Abstract: An English abstract should accompany all submissions except for Letters to the Editor.
Abstracts in Turkish are not expected from international authors. The abstract of Original Articles
should be structured with subheadings (Introduction, Methods, Results, and Conclusion). Please
check Table 1 below for word count specifications.

Keywords: Each submission must be accompanied by a minimum of three to a maximum of six
keywords for subject indexing at the end of the abstract. The keywords should be listed in full without

abbreviations. The keywords should be selected from the National Library of Medicine, Medical
Subject Headings (MeSH) database (https://www.nlm.nih.gov/mesh/MBrowser.html).

Manuscript Types

Research Articles: The main text of research articles should be organized under the subtitles of
Introduction, Methods, Results, and Discussion. The Introduction should include the rationale of the
study, and the objective should be clearly stated in the last paragraph. The Method section may
include subsections describing the participants, instruments, and the statistical methods. The Results
section includes the findings of the study, supported with tables and figures to facilitate viewing. The
Discussion should include the authors’ conclusions, limitations of the study and a comparison with
the relevant literature. Please check Table 1 below for word count specifications.
Statistical analyses must be conducted in accordance with international statistical reporting
standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to
medical journals. Br Med J 1983: 7; 1489-93). Information on statistical analyses should be provided
with a separate subheading under the Materials and Methods section and the statistical software that
was used during the process must be specified.

Units should be prepared in accordance with the International System of Units (SI).
Review Articles: Reviews should describe, discuss, and evaluate the current level of knowledge of a
topic that is in the journal’s scope and should guide future studies. Reviews prepared by authors who
have extensive knowledge on a particular field and whose scientific background has been translated
into a high volume of publications with a high citation potential are welcomed. Authors fulfilling those
requirements may be invited by the journal. Reviews can be submitted without editorial invitation if
one of the authors has published three or more original research articles on the subject. Authors
must be aware that the journal has limited space for reviews. Please check Table 1 below for word
count specifications.

Case Reports: There is limited space for case reports in the journal. Reports on rare cases or
conditions that constitute challenges in diagnosis and treatment, those offering new therapies or
revealing knowledge not included in the literature, and interesting and educative case reports are
accepted for review. The text should include the subheadings Introduction, Case Presentation, and
Discussion. Please check Table 1 below for word count specifications.

Brief Reports: These are manuscripts that report either original research or novel ideas dealing with
important theoretical or practical problems related to specific subjects. Subtitles of the main text can
be organized according to the text content. Please check Table 1 below for word count specifications
Letters to the Editor: These manuscripts include evaluation and criticisms submitted by the experts
in the field or the reviewers of a manuscript regarding manuscripts previously published in the
journal. The authors of manuscripts that become topics of letters to the editor are provided with the
opportunity to responds to the comments that are raised. Letters are published together with the
responses of the author(s) of the manuscript concerned where possible.

Special Section

Introduction of websites: These manuscripts introduce websites relevant to the scope of the
journal.

Book/thesis Section: These manuscripts introduce the books/theses published on subjects related
to the scope of the journal.
The text of manuscripts in the special section must not exceed 500 words (excluding the references,
tables, and figures or legends. Up to five references and either one table or one figure are allowed.